Crystalline form of beta2 adrenergic receptor agonist

Details for Australian Patent Application No. 2004243304 (hide)

Owner Theravance, Inc.

Inventors Zhang, Weijiang; Yost, Edward; Stergiades, Ioanna; Hubbard, Cristin

Agent Davies Collison Cave

Pub. Number AU-A-2004243304

PCT Pub. Number WO2004/106279

Priority 60/473,423 27.05.03 US

Filing date 26 May 2004

Wipo publication date 9 December 2004

International Classifications

C07C 233/43 Carboxylic acid amides

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 011/08 Drugs for disorders of the respiratory system

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/106279 Priority application(s): WO2004/106279

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243308-3 - [2- (3-amino-2-oxo-2H-pyridin-1-YL) - acetylamino] - 4oxo-pentanoic acid derivatives and their use as caspase inhibitors

2004243301-Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase1